Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2

Pachyonychia congenita type 2 (PC‐2; Jackson–Lawler syndrome) is an autosomal dominant disorder characterized by hypertrophic nail dystrophy, mild focal keratoderma, multiple pilosebaceous cysts and other features of ectodermal dysplasia. Keratin 17 (K17) is a differentiation‐specific keratin expressed in the nail bed, hair follicle, sebaceous gland and other epidermal appendages. Previously, we have demonstrated that PC‐2 is caused by mutations in K17 and that similar mutations in this gene can present as steatocystoma multiplex with little or no nail dystrophy. Here, we describe three unrelated kindreds carrying K17 mutations. Two of these families have identical missense mutations (R94C) in the 1A domain of K17. However, while affected members of one kindred have the classical features of PC‐2, affected persons in the other family have the steatocystoma multiplex phenotype. In a third family with PC‐2, mutation N92S was detected, bringing the total number of distinct mutations reported in K17 thus far to 11. These results demonstrate that K17 mutations commonly underlie both PC‐2 and steatocystoma multiplex and that the alternate phenotypes which arise from these genetic lesions in K17 are independent of the specific mutation involved.

[1]  E. Lane,et al.  Missense mutations in keratin 17 cause either pachyonychia congenita type 2 or a phenotype resembling steatocystoma multiplex. , 1997, The Journal of investigative dermatology.

[2]  W. McLean,et al.  Human keratin diseases: , 1996, Experimental dermatology.

[3]  J. Weissenbach,et al.  Linkage of an American pedigree with palmoplantar keratoderma and malignancy (palmoplantar ectodermal dysplasia type III) to 17q24. Literature survey and proposed updated classification of the keratodermas. , 1996, Archives of dermatology.

[4]  A. Hauschild,et al.  Eruptive vellus hair cysts and steatocystoma multiplex. Variants of one entity? , 1996, The British journal of dermatology.

[5]  D. Kelsell,et al.  Novel mutations in keratin 16 gene underly focal non-epidermolytic palmoplantar keratoderma (NEPPK) in two families. , 1995, Human molecular genetics.

[6]  J. Rothnagel,et al.  Mutation of a type II keratin gene (K6a) in pachyonychia congenita , 1995, Nature Genetics.

[7]  E. Lane,et al.  Keratin 16 and keratin 17 mutations cause pachyonychia congenita , 1995, Nature Genetics.

[8]  E. Lane,et al.  Intermediate filaments in disease. , 1995, Current opinion in cell biology.

[9]  R. Iozzo,et al.  Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. , 1994, Genes & development.

[10]  T. Strachan,et al.  A gene for pachyonychia congenita is closely linked to the keratin gene cluster on 17q12-q21. , 1994, Journal of medical genetics.

[11]  Y. Lee,et al.  Eruptive vellus hair cyst and steatocystoma multiplex in a patient with pachyonychia congenita. , 1994, Journal of the American Academy of Dermatology.

[12]  C. Hutchison,et al.  Intermediate filament proteins. , 1994, Protein profile.

[13]  S. Bale,et al.  Concurrence between the molecular overlap regions in keratin intermediate filaments and the locations of keratin mutations in genodermatoses. , 1993, Biochemical and biophysical research communications.

[14]  H. Baribault,et al.  Mid-gestational lethality in mice lacking keratin 8. , 1993, Genes & development.

[15]  D. Cooper,et al.  Human Gene Mutation , 1993 .

[16]  A. Letai,et al.  Disease severity correlates with position of keratin point mutations in patients with epidermolysis bullosa simplex. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. Parry,et al.  Keratin intermediate filament structure. Crosslinking studies yield quantitative information on molecular dimensions and mechanism of assembly. , 1993, Journal of molecular biology.

[18]  Beat Steinmann,et al.  Connective tissue and its heritable disorders —Molecular, genetic and medical aspects , 1993 .

[19]  R. Leube,et al.  Characterization of the human gene encoding cytokeratin 17 and its expression pattern. , 1992, European journal of cell biology.

[20]  A. Letai,et al.  Do the ends justify the mean? Proline mutations at the ends of the keratin coiled-coil rod segment are more disruptive than internal mutations , 1992, The Journal of cell biology.

[21]  L. Requena,et al.  Follicular Hybrid Cysts: An Expanded Spectrum , 1991, The American Journal of dermatopathology.

[22]  J. Garioch,et al.  Pachyonychia congenita complicated by hidradenitis suppurativa: a family study , 1990, The British journal of dermatology.

[23]  V. Krutovskikh,et al.  Patterns of expression of keratin 17 in human epithelia: dependency on cell position. , 1989, Journal of cell science.

[24]  Pachyonychia congenita Jackson‐Lawler type: a distinct malformation syndrome , 1986, The British journal of dermatology.

[25]  R. Dobson,et al.  British Association of Dermatologists , 2014 .

[26]  Robert J. Gorlin,et al.  Syndromes of the Head and Neck , 1976 .

[27]  V. McKusick Mendelian inheritance in man , 1971 .

[28]  S. Lawler,et al.  Pachyonychia congenita; a report of six cases in one family, with a note on linkage data. , 1951, Annals of eugenics.